Combined Abciximab Reteplase Stent Study in Acute Myocardial Infarction - CARESS-in-AMI: 30-Day and 1-Year Results


The goal of the trial was to evaluate immediate transfer for urgent percutaneous coronary intervention (PCI) or standard therapy and rescue PCI if needed among ST-elevation myocardial infarction (STEMI) patients admitted to centers without PCI facilities who were initially treated with heparin, half-dose reteplase, and abciximab.